Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostatic angiosarcoma: report of a new case].

J Oliva Encina1, P Gil Martínez, C Allepuz Losa

  • 1Servicio de Urología, Hospital Universitario Miguel Servet, Zaragoza.

Actas Urologicas Espanolas
|April 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3D printing utility for surgical treatment of acetabular fractures.

Revista espanola de cirugia ortopedica y traumatologia (English ed.)·2018
Same author

One of the greatest; the death of Francesc Xavier Solé Balcells (1924-2014).

Actas urologicas espanolas·2014
Same author

[Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms].

Archivos espanoles de urologia·2012
Same author

[Beyond the photodynamic diagnosis: Searching for excellence in the diagnosis of non-muscle-invasive bladder cancer].

Actas urologicas espanolas·2010
Same author

[A new case of malignant fibrous histiocytoma arising from the renal capsule].

Actas urologicas espanolas·2010
Same author

[Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors].

Actas urologicas espanolas·2008
Same journal

Comparative outcomes of Mini-PCNL and suction-assisted flexible ureteroscopy in patients with renal stones ≥2 cm.

Actas urologicas espanolas·2026
Same journal

Morphometric changes in pelvic floor structure following non-invasive rehabilitation and neuromodulation assessed by ultrasound imaging.

Actas urologicas espanolas·2026
Same journal

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same journal

i-PCNL: a novel ureteral-catheter application for continuous unidirectional high-flow irrigation during Percutaneous Nephrolithotomy. Technique description and preliminary outcomes.

Actas urologicas espanolas·2026
Same journal

Reconstructing the reconstructed: Outcomes of redo-urethroplasty for recurrent urethral strictures.

Actas urologicas espanolas·2026
Same journal

Functional outcomes of pyeloplasty in children with reduced preoperative renal function: A multicenter study.

Actas urologicas espanolas·2026
See all related articles

A rare prostate angiosarcoma was diagnosed in a 31-year-old male presenting with lower urinary tract symptoms. Successful treatment involved surgery and chemotherapy, with the patient remaining disease-free for over 36 months.

Area of Science:

  • Urology
  • Oncology
  • Vascular Oncology

Background:

  • Prostate angiosarcoma is an extremely rare vascular tumor.
  • Lower urinary tract symptoms (LUTS) can be the initial presentation.

Observation:

  • A 31-year-old male presented with LUTS.
  • Diagnostic workup confirmed prostate angiosarcoma.

Findings:

  • The patient underwent retropubic radical prostatectomy and partial bladder neck resection.
  • Adjuvant chemotherapy with Ifosfamide and Adriamycin was administered.
  • The patient achieved a complete response with no signs of recurrence at 36 months post-surgery.

Implications:

  • This case highlights the importance of considering rare diagnoses in young patients with LUTS.

Related Experiment Videos

  • Multimodal treatment including surgery and chemotherapy can lead to favorable outcomes.
  • Long-term oncological surveillance is crucial for patients with prostate angiosarcoma.